Lv3
308 积分 2021-02-28 加入
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
5天前
已关闭
构建和验证急诊患者急性肾损伤的风险预测模型
8天前
已完结
血清学指标联合序贯器官衰竭评估评分对重症急性肾损伤患者预后的预测价值
12天前
已完结
急性胃肠功能损伤分级指导下脓毒症患者早期肠内营养的效果及对近期预后的影响
12天前
已完结
老年慢性心力衰竭病人营养状态与不良心脏事件发生的关系
22天前
已完结
血清sST2、UA、ACT-A水平变化与年龄>60岁急性心衰患者MACE风险的关系
24天前
已完结
视网膜下注射和玻璃体腔注射康柏西普治疗息肉样脉络膜血管病变的疗效分析
26天前
已完结
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
3个月前
已完结
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
3个月前
已完结
两种康柏西普治疗方案治疗息肉样脉络膜血管病变的效果分析
3个月前
已完结
皖公网安备34019202002308
